Repeated ketamine administration redeems the time lag for citalopram's antidepressant-like effects
- 1 June 2015
- journal article
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 30 (4), 504-510
- https://doi.org/10.1016/j.eurpsy.2014.11.007
Abstract
Current available antidepressants exhibit low remission rate with a long response lag time. Growing evidence has demonstrated acute sub-anesthetic dose of ketamine exerts rapid, robust, and lasting antidepressant effects. However, a long term use of ketamine tends to elicit its adverse reactions. The present study aimed to investigate the antidepressant-like effects of intermittent and consecutive administrations of ketamine on chronic unpredictable mild stress (CUMS) rats, and to determine whether ketamine can redeem the time lag for treatment response of classic antidepressants. The behavioral responses were assessed by the sucrose preference test, forced swimming test, and open field test. In the first stage of experiments, all the four treatment regimens of ketamine (10 mg/kg ip, once daily for 3 or 7 consecutive days, or once every 7 or 3 days, in a total 21 days) showed robust antidepressant-like effects, with no significant influence on locomotor activity and stereotype behavior in the CUMS rats. The intermittent administration regimens produced longer antidepressant-like effects than the consecutive administration regimens and the administration every 7 days presented similar antidepressant-like effects with less administration times compared with the administration every 3 days. In the second stage of experiments, the combination of ketamine (10 mg/kg ip, once every 7 days) and citalopram (20 mg/kg po, once daily) for 21 days caused more rapid and sustained antidepressant-like effects than citalopram administered alone. In summary, repeated sub-anesthestic doses of ketamine can redeem the time lag for the antidepressant-like effects of citalopram, suggesting the combination of ketamine and classic antidepressants is a promising regimen for depression with quick onset time and stable and lasting effects.Keywords
Funding Information
- National Natural Science Foundation of China (81271216)
This publication has 46 references indexed in Scilit:
- Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressantsFrontiers in Pharmacology, 2013
- Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampusPsychopharmacology, 2012
- Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major DepressionBiological Psychiatry, 2012
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responsesNature, 2011
- Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in miceMolecular Psychiatry, 2011
- Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamineMetabolic Brain Disease, 2011
- Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming testPsychopharmacology, 2010
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant DepressionBiological Psychiatry, 2010
- Antidepressant effects of ketamine in depressed patientsBiological Psychiatry, 2000
- Comparison of Ketamine-Induced Thought Disorder in Healthy Volunteers and Thought Disorder in SchizophreniaAmerican Journal of Psychiatry, 1999